Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set.

作者信息

Pantalone Kevin M, Misra-Hebert Anita D, Hobbs Todd M, Ji Xinge, Kong Sheldon X, Milinovich Alex, Weng Wayne, Bauman Janine, Ganguly Rahul, Burguera Bartolome, Kattan Michael W, Zimmerman Robert S

机构信息

Endocrinology & Metabolism Institute, Cleveland Clinic, Cleveland, OH

Medicine Institute, Cleveland Clinic, Cleveland, OH.

出版信息

Diabetes Care. 2018 Jul;41(7):e113-e114. doi: 10.2337/dc18-0116. Epub 2018 Apr 20.

DOI:10.2337/dc18-0116

PMID:29678811

Abstract

摘要

相似文献

[1]

Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set.

Diabetes Care. 2018-7

[2]

Therapeutic inertia in the management of hyperlipidaemia in type 2 diabetic patients: a cross-sectional study in the primary care setting.

Hong Kong Med J. 2016-8

[3]

Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus.

Diabetes Res Clin Pract. 2014-5-27

[4]

[Clinical inertia in the management of patients with type 2 diabetes: how to solve it?].

Rev Med Liege. 2010

[5]

Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes.

J Endocrinol Invest. 2018-10-6

[6]

Family physician clinical inertia in glycemic control among patients with type 2 diabetes.

Med Sci Monit. 2015-2-5

[7]

Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study.

Diabet Med. 2015-3

[8]

Direct real-time neural evidence for task-set inertia.

Psychol Sci. 2015-3

[9]

Clinical Inertia and Outpatient Medical Errors

2005-2

[10]

Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus.

Diabetes Metab. 2017-7-25

引用本文的文献

[1]

Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review.

Diabetes Obes Metab. 2025-4

[2]

What Primary Care Clinicians Need to Know About Once-Weekly Insulins.

Fed Pract. 2024-11

[3]

A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes-2nd Edition (English version).

Diabetol Int. 2024-7-11

[4]

A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes - 2nd edition (English version).

J Diabetes Investig. 2024-9

[5]

Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system.

Sci Transl Med. 2024-7-10

[6]

Therapeutic Inertia in the Management of Type 2 Diabetes: A Narrative Review.

Diabetes Ther. 2024-3

[7]

Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes.

J Diabetes Investig. 2024-2

[8]

Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes-So Why Is Their Uptake So Low?

Clin Diabetes. 2023

[9]

Personalized Virtual Care Using Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Less Intensive Therapies.

Clin Diabetes. 2023-3-15

[10]

Transparent machine learning suggests a key driver in the decision to start insulin therapy in individuals with type 2 diabetes.

J Diabetes. 2023-3

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献